CSIMarket
 



Astria Therapeutics inc   (ATXS)
Other Ticker:  
 
 



 

What are Astria Therapeutics Inc's Business Segments?



Astria Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for various diseases. The company offers a wide range of segments, products, and services, which are described below:

Segments:
1. Neurology: Astria Therapeutics Inc develops therapies for the treatment of neurological disorders, such as Parkinson's disease, Alzheimer's disease, and multiple sclerosis.
2. Oncology: The company also focuses on developing therapies for the treatment of different types of cancer, including breast cancer, lung cancer, and pancreatic cancer.
3. Rare Diseases: Astria Therapeutics Inc develops therapies for rare diseases, such as Gaucher disease, Fabry disease, and Pompe disease.
4. Immunology: The company has also developed therapies for the treatment of immune-related disorders, including rheumatoid arthritis, psoriasis, and lupus.

Products:
1. ATP-200: It is a small molecule drug that Astria Therapeutics Inc developed for the treatment of Parkinson's disease. It enhances dopamine release in the brain, which reduces the symptoms of Parkinson's disease.
2. ATP-400: It is a small molecule drug that the company developed for the treatment of Alzheimer's disease. It reduces the aggregation of amyloid beta proteins, which is one of the causes of Alzheimer's disease.
3. ATP-300: It is a small molecule drug that the company developed for the treatment of multiple sclerosis. It reduces the inflammation and demyelination of nerve fibers, which is the leading cause of multiple sclerosis.
4. ATP-500: It is a small molecule drug that the company is developing for the treatment of breast cancer. It targets the cancer stem cells, which are responsible for recurrence and metastasis.

Services:
1. Clinical Trials: Astria Therapeutics Inc conducts various clinical trials to test its therapies' safety and efficacy. The company's clinical trial services include study design, patient recruitment, and monitoring.
2. Drug Discovery: The company's drug discovery services include target identification, lead optimization, and preclinical development.
3. Contract Manufacturing: Astria Therapeutics Inc provides contract manufacturing services to other biopharmaceutical companies for the production of small molecule drugs and biologics.
4. Licensing: Astria Therapeutics Inc licenses its technology and intellectual property to other companies in the biopharmaceutical industry for the development of new therapies.

In summary, Astria Therapeutics Inc offers a diversified portfolio of segments, products, and services that cater to patients with various diseases. The company's innovative therapies and services focus on improving patients' health outcomes and quality of life.
   

Astria Therapeutics Inc Tax Rate Companies within the Major Pharmaceutical Preparations Industry



To get more information on Astria Therapeutics Inc's segment. Select each division with the arrow.


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com